Background and objective Post-finasteride syndrome (PFS) refers to a set of persistent symptoms reported by patients after discontinuation of 5-alpha-reductase inhibitors (5-ARIs). This study aimed to explore the perception of PFS among dermatologists belonging to […]
Background and objective Coronavirus disease 2019 (COVID-19) associated telogen effluvium (CATE) has been observed in patients after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it is self-limiting, hair loss can be very […]
The diagnosis of alopecia has traditionally relied on distinguishing between scarring and non-scarring forms, a differentiation that is not always straightforward from either a clinical or histopathological perspective. While the histopathological features of various types […]
Background Botulinum toxin A has emerged as an alternative treatment for patients who have contraindications to other therapies or as an adjuvant therapy in the treatment of androgenetic alopecia (AGA), although little is known about […]
Low-dose oral minoxidil (≤5mg daily) has emerged as an effective off-label treatment for androgenetic alopecia, outperforming topical minoxidil in terms of adherence. However, the optimal dose has not yet been determined, and high doses may […]
Background and objective Systemic adverse effects (AE) are a major concern of low-dose oral minoxidil (LDOM) treatment, especially in patients with arterial hypertension or arrhythmia. The objective of this study was to evaluate the safety […]
Trichoscopy is an essential tool in the evaluation of alopecia. The current compilation of trichoscopic signs in this setting helps distinguish between different forms of hair loss and has improved our understanding of the pathogenic […]